COVID-19 and selective vulnerability to Parkinson's disease.

Pavel, Alexandra; Murray, Danielle K; Stoessl, A Jon

Pavel, Alexandra; Murray, Danielle K; Stoessl, A Jon.

Pavel A; Division of Neurology, Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T2B5, Canada.
Murray DK; Division of Neurology, Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T2B5, Canada.
Stoessl AJ; Division of Neurology, Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T2B5, Canada. Electronic address: jstoessl@mail.ubc.ca.

Lancet Neurol ; 19(9): 719, 2020 09.

Article in English | MEDLINE | ID: covidwho-719059

Subject(s)

Betacoronavirus/metabolism; Coronavirus Infections/metabolism; Disease Susceptibility/metabolism; Parkinson Disease/metabolism; Pneumonia, Viral/metabolism; Animals; COVID-19; Coronavirus Infections/epidemiology; Disease Susceptibility/epidemiology; Humans; Pandemics; Parkinson Disease/epidemiology; Phosphorylation/physiology; Pneumonia, Viral/epidemiology; SARS-CoV-2; alpha-Synuclein/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Pneumonia, Viral / Coronavirus Infections / Disease Susceptibility / Betacoronavirus Type of study: Observational study Limits: Animals / Humans Language: English Journal: Lancet Neurol Journal subject: Neurology Year: 2020 Document Type: Article Affiliation country: S1474-4422(20)30269-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google